for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Zoetis Inc

ZTS.N

Latest Trade

160.89USD

Change

0.51(+0.32%)

Volume

229,032

Today's Range

160.00

 - 

162.42

52 Week Range

90.20

 - 

176.50

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Latest Developments

Zoetis Reports Q3 Adjusted Earnings Per Share Of $1.10

Nov 5 (Reuters) - Zoetis Inc <ZTS.N>::ZOETIS ANNOUNCES THIRD QUARTER 2020 RESULTS.Q3 ADJUSTED EARNINGS PER SHARE $1.10.Q3 REVENUE $1.8 BILLION VERSUS REFINITIV IBES ESTIMATE OF $1.63 BILLION.SEES FY 2020 EARNINGS PER SHARE $3.38 TO $3.45.Q3 EARNINGS PER SHARE $1.00.SEES FY 2020 REVENUE $6.55 BILLION TO $6.625 BILLION.SEES FY 2020 ADJUSTED EARNINGS PER SHARE $3.76 TO $3.81.Q3 EARNINGS PER SHARE ESTIMATE $0.91 -- REFINITIV IBES DATA.FY2020 REVENUE VIEW $6.43 BILLION -- REFINITIV IBES DATA.FY2020 EARNINGS PER SHARE VIEW $3.64 -- REFINITIV IBES DATA.

Zoetis Q2 Adjusted Earnings Per Share $0.89

Aug 6 (Reuters) - Zoetis Inc <ZTS.N>::ZOETIS ANNOUNCES SECOND QUARTER 2020 RESULTS.Q2 ADJUSTED EARNINGS PER SHARE $0.89.Q2 EARNINGS PER SHARE $0.79.SEES FY 2020 EARNINGS PER SHARE $3.14 TO $3.32.SEES FY 2020 REVENUE $6.3 BILLION TO $6.475 BILLION.Q2 REVENUE $1.5 BILLION VERSUS REFINITIV IBES ESTIMATE OF $1.36 BILLION.SEES FY 2020 ADJUSTED EARNINGS PER SHARE $3.52 TO $3.68.Q2 EARNINGS PER SHARE ESTIMATE $0.64 -- REFINITIV IBES DATA.LOOKING AHEAD, EXPECT OVERALL REVENUE GROWTH FOR REMAINDER OF YEAR TO BE DRIVEN LARGELY BY COMPANION ANIMAL PRODUCTS.

Zoetis Says Pricing Of $1.25 Billion Of Senior Notes

May 7 (Reuters) - Zoetis Inc <ZTS.N>::ZOETIS ANNOUNCES PRICING OF $1.25 BILLION OF SENIOR NOTES.AGREED TO SELL $1.25 BILLION OF SENIOR NOTES, CONSISTING OF $750 MILLION AGGREGATE PRINCIPAL AMOUNT OF 2.000% SENIOR NOTES DUE 2030.AGREED TO SELL $1.25 BILLION OF SENIOR NOTES CONSISTING OF $500 MILLION AGGREGATE PRINCIPAL AMOUNT OF 3.000% SENIOR NOTES DUE 2050.

Zoetis Reports Q1 Adjusted Earnings Per Share $0.95

May 6 (Reuters) - Zoetis Inc <ZTS.N>::ZOETIS ANNOUNCES FIRST QUARTER 2020 RESULTS.Q1 ADJUSTED EARNINGS PER SHARE $0.95.Q1 EARNINGS PER SHARE $0.88.Q1 REVENUE $1.5 BILLION VERSUS REFINITIV IBES ESTIMATE OF $1.5 BILLION.SEES FY 2020 EARNINGS PER SHARE $2.80 TO $3.07.SEES FY 2020 REVENUE $5.95 BILLION TO $6.25 BILLION.Q1 EARNINGS PER SHARE ESTIMATE $0.86 -- REFINITIV IBES DATA.IN Q1, PANDEMIC HAD LIMITED IMPACT ON CO'S RESULTS.ZOETIS - EXPECT MORE SIGNIFICANT IMPACT FROM COVID-19 FOR FULL YEAR AS LOCKDOWNS AND RECESSION HAVE CONTINUED IMPACT ON BUSINESS.SEES FY 2020 ADJUSTED DILUTED EPS BETWEEN $3.17 AND $3.42.FY2020 EARNINGS PER SHARE VIEW $3.70, REVENUE VIEW $6.42 BILLION -- REFINITIV IBES DATA.

Zoetis Says CEO Juan Ramón Alaix's FY 2019 Total Compensation Was $21.1 Mln Vs $11.7 Mln In 2018

April 6 (Reuters) - Zoetis Inc <ZTS.N>::ZOETIS INC SAYS CEO JUAN RAMÓN ALAIX'S FY 2019 TOTAL COMPENSATION WAS $21.1 MILLION VERSUS $11.7 MILLION IN 2018 - SEC FILING.ZOETIS INC - 2019 RATIO OF CEO PAY TO MEDIAN EMPLOYEE’S PAY WAS 275 TO 1.ZOETIS - EXCLUDING ONE-TIME MODIFICATION CHARGE, CEO PAY RATIO WOULD HAVE BEEN 169 TO 1.

Zoetis Receives FDA Approval For Simparica Trio

Feb 27 (Reuters) - Zoetis Inc <ZTS.N>::ZOETIS RECEIVES FDA APPROVAL FOR SIMPARICA TRIO™, A NEW COMBINATION PARASITE PREVENTATIVE FOR DOGS.ZOETIS - EXPECTS SIMPARICA TRIO TO BE AVAILABLE TO VETERINARY CUSTOMERS BY MID-TO-LATE APRIL.

Zoetis Reports Q4 EPS Of $0.80

Feb 13 (Reuters) - Zoetis Inc <ZTS.N>::ZOETIS REPORTS FOURTH QUARTER AND FULL YEAR 2019 RESULTS.Q4 ADJUSTED EARNINGS PER SHARE $0.92.Q4 EARNINGS PER SHARE $0.80.Q4 REVENUE $1.7 BILLION VERSUS REFINITIV IBES ESTIMATE OF $1.64 BILLION.SEES FY 2020 EARNINGS PER SHARE $3.53 TO $3.65.SEES FY 2020 REVENUE $6.65 BILLION TO $6.8 BILLION.SEES FY 2020 ADJUSTED EARNINGS PER SHARE $3.90 TO $4.00.Q4 EARNINGS PER SHARE ESTIMATE $0.88 -- REFINITIV IBES DATA.FY2020 EARNINGS PER SHARE VIEW $4.01, REVENUE VIEW $6.70 BILLION -- REFINITIV IBES DATA.Q4 REVENUE VIEW $1.64 BILLION -- REFINITIV IBES DATA.

Zoetis Inc Acquires Ethos Diagnostic Science

Feb 7 (Reuters) - Zoetis Inc <ZTS.N>::ZOETIS ACQUIRES ETHOS DIAGNOSTIC SCIENCE, A VETERINARY REFERENCE LAB BUSINESS, TO FURTHER EXPAND ITS COMPREHENSIVE DIAGNOSTICS CAPABILITIES.ZOETIS INC - FINANCIAL TERMS OF TRANSACTION ARE NOT BEING DISCLOSED.

Zoetis Declares First Quarter 2020 Dividend Board Approves 22% Payment Increase

Dec 11 (Reuters) - Zoetis Inc <ZTS.N>::ZOETIS DECLARES FIRST QUARTER 2020 DIVIDEND; BOARD APPROVES 22% PAYMENT INCREASE.ZOETIS INC - BOARD HAS DECLARED A Q1 2020 DIVIDEND PAYABLE TO HOLDERS OF COMPANY'S COMMON STOCK OF $0.20 PER SHARE.

Zoetis Acquires Znlabs To Strengthen Its Comprehensive Diagnostics Portfolio

Nov 22 (Reuters) - Zoetis Inc <ZTS.N>::ZOETIS ACQUIRES ZNLABS, A NATIONWIDE VETERINARY REFERENCE LABORATORY, TO FURTHER STRENGTHEN ITS COMPREHENSIVE DIAGNOSTICS PORTFOLIO.ZOETIS INC - FINANCIAL TERMS OF TRANSACTION ARE NOT BEING DISCLOSED.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up